Intramuscular Hemangioma Diagnosis and Treatment

Intramuscular hemangiomas are rare benign vascular tumours arising within skeletal muscle, representing under 1% of all hemangiomas. They typically present as a slowly enlarging, painless or mildly tender mass, often in the extremities or head and neck region. Diagnosis relies on a combination of clinical examination and imaging: ultrasound may reveal a heterogeneous, hypervascular lesion; magnetic resonance imaging provides high-resolution delineation, with characteristic high-signal intensity on T2-weighted sequences and signal voids corresponding to phleboliths. Histopathological confirmation remains the gold standard, distinguishing capillary, cavernous and mixed subtypes. Treatment is guided by symptom severity, lesion size and location. Complete surgical excision with preservation of surrounding function is the mainstay for accessible tumours, whereas percutaneous sclerotherapy, embolisation or cryoablation are increasingly employed to reduce vascularity preoperatively or as definitive therapy in anatomically challenging sites. Pharmacological agents targeting angiogenic pathways have shown promise in reducing lesion bulk and mitigating recurrence. Multidisciplinary management involving radiologists, surgeons and pathologists is essential to optimise functional and cosmetic outcomes.

Research from Nature Portfolio

Recent studies have harnessed advanced imaging algorithms and artificial-intelligence-driven analysis to improve differentiation between intramuscular hemangiomas and other soft-tissue masses. Dynamic contrast-enhanced magnetic resonance sequences combined with machine-learning models have achieved higher sensitivity in identifying intralesional vascular channels and predicting growth potential. Concurrent molecular profiling of resected specimens has revealed upregulation of vascular endothelial growth factor signalling and mTOR pathway components, paving the way for off-label use of angiogenesis inhibitors and sirolimus derivatives in refractory cases. Early clinical series report that incorporating these targeted therapies alongside minimally invasive ablation reduces lesion volume and decreases postoperative recurrence rates, signalling a shift towards personalised, biology-driven treatment paradigms.

Intramuscular Hemangioma Diagnosis and Treatment publication trend

The graph below shows the total number of articles in intramuscular hemangioma diagnosis and treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Intramuscular hemangioma: A benign vascular tumour located within skeletal muscle fibres.

Dynamic contrast-enhanced MRI: Imaging technique capturing temporal changes in signal intensity after contrast injection to assess vascularity.

Sclerotherapy: Percutaneous injection of a sclerosant agent to induce vessel occlusion and lesion regression.

Phlebolith: Calcified thrombus within a venous channel, appearing as signal voids or calcifications on imaging.

Embolisation: Endovascular procedure to block arterial supply to a lesion, reducing blood flow and lesion size.